MARKET WIRE NEWS

Exagen Inc. (XGN) Q4 2024 Earnings Call Transcript

Source: SeekingAlpha

2025-03-11 13:13:02 ET

Exagen Inc. (XGN)

Q4 2024 Results Conference Call

March 11, 2025 08:30 AM ET

Company Participants

Ryan Douglas - Investor Relations

John Aballi - President & Chief Executive Officer

Jeff Black - Chief Financial Officer

Conference Call Participants

Kyle Mikson - Canaccord Genuity

Ross Osborn - Cantor Fitzgerald

Mark Massaro - BTIG

Dan Brennan - TD Cowen

Andrew Brackmann - William Blair

Matthew Parisi - KeyBanc

Presentation

Operator

Greetings, and welcome to Exagen Inc. Fourth Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.

It is now my pleasure to introduce your host, Ryan Douglas, Investor Relations. Thank you. You may begin.

Ryan Douglas

Good morning, and thank you for joining us.

Earlier today, Exagen Inc. Released financial results for the quarter and year ended December 31, 2024. John Aballi, our President and Chief Executive Officer; and Jeff Black, our Chief Financial Officer, will host this morning's call. A recording of today's call and the press release announcing our results can be found on the company's website at www.exagen.com.

As today's call includes forward-looking statements, we encourage you to review the statements contained in today's press release and the risks and uncertainties described in our SEC filings, which identify certain factors that may cause the company's actual events, performance and results to differ materially from those contained in the forward-looking statements made on today's call.

In addition, we will discuss non GAAP financial measures on this call. Descriptions of these non-GAAP financial measures and reconciliations of GAAP to non-GAAP measures are included in today's press release.

I'll now turn the call over to John.

John Aballi

Good morning, and thanks to everyone for being on the call today. I'll start off by recapping our results from 2024, give some color from the launch of our new markers and comment on our outlook for 2025. Jeff will provide additional detail on the financials later in the call....

Read the full article on Seeking Alpha

For further details see:

Exagen Inc. (XGN) Q4 2024 Earnings Call Transcript
Exagen Inc.

NASDAQ: XGN

XGN Trading

-8.28% G/L:

$3.12 Last:

260,124 Volume:

$3.17 Open:

mwn-ir Ad 300

XGN Latest News

XGN Stock Data

$80,000,739
13,869,817
3.15%
15
N/A
Medical Diagnostics & Screening
Healthcare
US
Vista

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App